From overwhelming happiness to disbelief, moms share what it felt like when they finally got the call they'd been waiting for ...

Phase 3 SELVA study evaluating QTORIN™ rapamycin 3.9% anhydrous gel (QTORIN™ rapamycin) for microcystic lymphatic ...

Despite their dominant defense, the Broncos have committed more turnovers than they've forced. Can they improve their ...

Zevia is a high-growth, health-focused beverage company with double-digit revenue gains and strong distribution expansion.

CEO Geoff Tanner opened by expressing confidence in the company’s plan and reaffirmed the full year outlook for net sales and adjusted EBITDA. Tanner highlighted, “Consumption in Q1 grew 2%, led by ...

The reasonable headline index return masks the fact that 2025 was a sombre year for most stocks, which should put the ...

Learn about comparable store sales, a measure of revenue growth relative to previous periods, and discover how it helps evaluate a retail location's performance.

Plenty of people – about 1 in 3, according to some studies — feel bad for a day or two after they get a flu shot. The most common symptoms include headaches, muscle aches, fatigue and fever, all of ...

US earnings show rare strength with rising Q4 estimates and robust margins. Tech leadership and 2026 growth outlook support ...

Laura Huppert, MD, discusses efficacy and safety outcomes from the phase 3 ASCENT-04 trial, which compared the combination of ...

China NMPA grants breakthrough therapy designation to Kelun-Biotech’s sacituzumab tirumotecan in combo with immunotherapy pembrolizumab for first-line treatment of PD-L1-positive NSCLC ...

U.S. spot Bitcoin ETFs pulled in $697M as BTC held above a key $93.7K trendline, setting up a crucial technical test.